Castle Biosciences, Inc. (CSTL)

USD 26.52

(-5.76%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 477.81 Million 447.32 Million 462.57 Million 439.32 Million 119.74 Million 22.4 Million
Total Current Assets 295.63 Million 292.28 Million 353.74 Million 429.59 Million 116.68 Million 18.12 Million
Cash And Short Term Investments 243.09 Million 258.62 Million 329.63 Million 409.85 Million 98.84 Million 4.47 Million
Cash and Cash Equivalents 98.84 Million 122.94 Million 329.63 Million 409.85 Million 98.84 Million 4.47 Million
Short Term Investments 144.25 Million 135.67 Million - - - -
Net Receivables 38.3 Million 23.47 Million 17.28 Million 12.75 Million 14.64 Million 12.08 Million
Inventory 7.94 Million 3.98 Million 2.02 Million 2.21 Million 1.23 Million 882.23 Thousand
Other Current Assets 6.29 Million 6.2 Million 4.8 Million 4.76 Million 1.95 Million 675.56 Thousand
Total Non-Current Assets 182.17 Million 155.04 Million 108.82 Million 9.73 Million 3.06 Million 4.27 Million
Net PPE 37.73 Million 26.49 Million 16.88 Million 7.1 Million 2.06 Million 1.52 Million
Good Will And Intangible Assets 117.33 Million 126.34 Million 88.92 Million - - 4167.00
Good Will 10.69 Million 10.69 Million - - - -
Intangible Assets 106.64 Million 115.65 Million 88.92 Million - - 4167.00
Long-Term Investments 1.19 Million 1.08 Million 1.3 Million 1.09 Million 870 Thousand 2.53 Million
Tax Assets 24.47 Million 26.68 Million -1.3 Million - - -2.53 Million
Other Non Current Assets 1.44 Million -25.57 Million 3.02 Million 1.53 Million 135 Thousand 2.74 Million
Other Assets - - - - - -
Total Liabilities 86.54 Million 48.17 Million 50.83 Million 23.63 Million 34.63 Million 32.47 Million
Total Current Liabilities 47.66 Million 36.12 Million 24.88 Million 20.87 Million 15.28 Million 6.73 Million
Account Payables 10.26 Million 4.73 Million 2.54 Million 2.09 Million 1.86 Million 1.45 Million
Tax Payables - 37 Thousand 695 Thousand 62 Thousand 79 Thousand 8606.00
Short Term Debt 1.13 Million 1.77 Million 1.17 Million - 5.83 Million -
Deferred Revenue - - - 6.61 Million - -
Other Current Liabilities 36.26 Million 29.62 Million 21.16 Million 12.16 Million 7.59 Million 5.28 Million
Total Non Current Liabilities 38.87 Million 12.05 Million 25.94 Million 2.76 Million 19.34 Million 25.73 Million
Long-Term Debt 14.19 Million 11.53 Million 6.9 Million - 19.28 Million 24.49 Million
Deferred Revenue Non Current -25 Thousand - - 1.73 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 25 Thousand 90 Thousand 18.41 Million 1.02 Million 55 Thousand 1.23 Million
Other Liabilities - - - - - -
Total Equity 391.26 Million 399.15 Million 411.74 Million 415.69 Million 85.11 Million -10.06 Million
Stock Holders Equity 391.26 Million 399.15 Million 411.74 Million 415.69 Million 85.11 Million -10.06 Million
Common Stock 27 Thousand 27 Thousand 25 Thousand 25 Thousand 17 Thousand 1916.00
Retained Earnings -218.37 Million -160.9 Million -93.76 Million -62.49 Million -52.21 Million -57.48 Million
Accumulated other comprehensive income 136 Thousand -381 Thousand - - -119.74 Million -909.38 Thousand
Common Stock Equity 391.26 Million 399.15 Million 411.74 Million 415.69 Million 85.11 Million -10.06 Million
Capital Lease Obligation 14.17 Million 13.31 Million 8.07 Million - - -
Total Investments 145.44 Million 135.67 Million 1.3 Million 1.09 Million 870 Thousand 2.53 Million
Total Debt 15.31 Million 13.31 Million 8.07 Million - 25.12 Million 24.49 Million
Net Debt -83.53 Million -109.63 Million -321.55 Million -409.85 Million -73.72 Million 20.02 Million

Balance Sheet Charts